| Clip | Code No. | Product | Data | ||||
|---|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Price | Availability | |
| Sequence | Location (aa) | Storage
temp. |
|||||
|
|
|||||||
|
TS-M223-1 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-VLENFTIFLV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLENFTIFLV | 4°C | ||||||
|
TS-M221-1 |
HLA-A*02:01 GANAB Neoepitope Tetramer-ALYGFVPVL-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALYGFVPVL | 4°C | ||||||
|
TS-M208-1 |
HLA-A*02:01 p53 Neoepitope Tetramer-VVPCEPPEV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVPCEPPEV | 4°C | ||||||
|
TC-8020-2 |
HLA-A*02:01 PSMA663-671 Tetramer-MMNDQLMFL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| MMNDQLMFL | 663-671 | 4°C | |||||
|
TC-8009-2 |
HLA-A*02:01 MAGE-A4286-294 Tetramer-KVLEHVVRV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KVLEHVVRV | 286-294 | 4°C | |||||
|
TC-8007-2 |
HLA-A*02:01 P53168-176 Tetramer-HMTEVVRRC-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| HMTEVVRRC | 168-176 | 4°C | |||||
|
TS-M268-2 |
HLA-A*24:02 p53 Tetramer-TYSPALNKMF-APC
|
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| TYSPALNKMF | 125-134 | 4°C | |||||
|
TS-M267-2 |
HLA-A*24:02 LOK Tetramer-SYQKVIELF-APC
|
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYQKVIELF | 289-297 | 4°C | |||||
|
TS-M260-2 |
HLA-A*11:01 CDK13 Neoepitope Tetramer-CILGKLFTK-APC
|
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| CILGKLFTK | 4°C | ||||||
|
TS-M247-2 |
HLA-A*02:01 AGMO Neoepitope Tetramer-ALLQVTLLL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALLQVTLLL | 4°C | ||||||
|
TS-M238-2 |
HLA-A*02:01 SNAT1 Neoepitope Tetramer-ILAALFLGL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILAALFLGL | 4°C | ||||||
|
TS-M237-2 |
HLA-A*02:01 GCN1 Neoepitope Tetramer-ALLETPSLLL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALLETPSLLL | 4°C | ||||||
|
TS-M223-2 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-VLENFTIFLV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLENFTIFLV | 4°C | ||||||
|
TS-M216-2 |
HLA-A*02:01 HAUS3 Neoepitope Tetramer-ILNAMIAKI-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILNAMIAKI | 4°C | ||||||
|
TS-M208-2 |
HLA-A*02:01 p53 Neoepitope Tetramer-VVPCEPPEV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVPCEPPEV | 4°C | ||||||
|
TS-M268-1 |
HLA-A*24:02 p53 Tetramer-TYSPALNKMF-PE
|
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| TYSPALNKMF | 125-134 | 4°C | |||||
|
TS-M265-1 |
HLA-A*24:02 β-catenin Neoepitope Tetramer-SYLDSGIHF-PE
|
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYLDSGIHF | 4°C | ||||||
|
TS-M234-1 |
HLA-A*02:01 GAS7 Neoepitope Tetramer-SLADEAEVYL-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLADEAEVYL | 4°C | ||||||
|
TS-M232-1 |
HLA-A*02:01 MRM1 Neoepitope Tetramer-LLFGMPPCL-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LLFGMPPCL | 4°C | ||||||
|
TS-M225-1 |
HLA-A*02:01 Hsp70 Neoepitope Tetramer-SLFEGIDIYT-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLFEGIDIYT | 4°C | ||||||
|
TS-M222-1 |
HLA-A*02:01 NSDHL Neoepitope Tetramer-ILTGLNYEV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILTGLNYEV | 4°C | ||||||
|
TS-M218-1 |
HLA-A*02:01 ACTN1 Neoepitpe Tetramer-FIASNGVKLV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FIASNGVKLV | 4°C | ||||||
|
TS-M211-1 |
HLA-A*02:01 HER2 Neoepitope Tetramer-ALIHHNTYL-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALIHHNTYL | 4°C | ||||||
|
TS-M209-1 |
HLA-A*02:01 SRPX Neoepitope Tetramer-TLWCSPIKV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| TLWCSPIKV | 4°C | ||||||
|
TC-8024-1 |
HLA-A*02:01 KRAS5-14 WT Tetramer-KLVVVGAGGV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLVVVGAGGV | 5-14 | 4°C | |||||
|
TC-8019-1 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | 4°C | |||||
|
TC-8007-1 |
HLA-A*02:01 P53168-176 Tetramer-HMTEVVRRC-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| HMTEVVRRC | 168-176 | 4°C | |||||
|
TS-M610-2 |
H-2Kb SGK1 Tetramer-STLTYSRM-APC
|
|
||||
|
cancer | APC | H-2Kb | 50 tests | ¥209,000 |
0 (Contact us) |
|
| STLTYSRM | 10-17 | 4°C | |||||
|
TS-M246-2 |
HLA-A*02:01 GOLGA3 Neoepitope Tetramer-SLDLTTSPV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLDLTTSPV | 4°C | ||||||
|
TS-M243-2 |
HLA-A*02:01 UGCGL2 Neoepitope Tetramer-GLLDEDFYA-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLLDEDFYA | 4°C | ||||||
|
TS-M232-2 |
HLA-A*02:01 MRM1 Neoepitope Tetramer-LLFGMPPCL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LLFGMPPCL | 4°C | ||||||
|
TS-M227-2 |
HLA-A*02:01 KMT2D Neoepitope Tetramer-ALSPVIPHI-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALSPVIPHI | 4°C | ||||||
|
TS-M224-2 |
HLA-A*02:01 CDC37L1 Neoepitope Tetramer-FLSDHLYLV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLSDHLYLV | 4°C | ||||||
|
TS-M218-2 |
HLA-A*02:01 ACTN1 Neoepitpe Tetramer-FIASNGVKLV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FIASNGVKLV | 4°C | ||||||
|
TS-M215-2 |
HLA-A*02:01 WDR46 Neoepitope Tetramer-FLIYLDVSV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLIYLDVSV | 4°C | ||||||
|
TS-M214-2 |
HLA-A*02:01 COL18A1 Neoepitope Tetramer-VLLGVKLFGV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLLGVKLFGV | 4°C | ||||||
|
TS-M211-2 |
HLA-A*02:01 HER2 Neoepitope Tetramer-ALIHHNTYL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALIHHNTYL | 4°C | ||||||
|
TS-M207-2 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ALDPHSGHFV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALDPHSGHFV | 4°C | ||||||
|
TS-M266-1 |
HLA-A*24:02 COASY Neoepitope Tetramer-RFLEYLPLRF-PE
|
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RFLEYLPLRF | 4°C | ||||||
|
TS-M245-1 |
HLA-A*02:01 Sarcospan Neoepitope Tetramer-LMASISSFL-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LMASISSFL | 4°C | ||||||
|
TS-M241-1 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLA-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLFGDIYLA | 4°C | ||||||
|
TS-M231-1 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| NLNCCSVPV | 4°C | ||||||
|
TS-M229-1 |
HLA-A*02:01 SNX24 Neoepitope Tetramer-KLSHQLVLL-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLSHQLVLL | 4°C | ||||||
|
TS-M228-1 |
HLA-A*02:01 PGML5 Neoepitope Tetramer-AVGSYVYSV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| AVGSYVYSV | 4°C | ||||||
|
TS-M226-1 |
HLA-A*02:01 Astrotactin-1 Neoepitope Tetramer-KLYGLDWAEL-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLYGLDWAEL | 4°C | ||||||
|
TS-M219-1 |
HLA-A*02:01 SMARCD3 Neoepitope Tetramer-KLFEFLVYGV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLFEFLVYGV | 4°C | ||||||
|
TS-M217-1 |
HLA-A*02:01 ME3 Neoepitope Tetramer-FLDEFMEGV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLDEFMEGV | 4°C | ||||||
|
TS-M207-1 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ALDPHSGHFV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALDPHSGHFV | 4°C | ||||||
|
TS-M258-2 |
HLA-A*11:01 KRAS Neoepitope Tetramer-VVGAAGVGK-APC
|
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAAGVGK | 4°C | ||||||
|
TS-M244-2 |
HLA-A*02:01 FNDC3B Neoepitope Tetramer-VVMSWAPPV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVMSWAPPV | 4°C | ||||||
|
TS-M242-2 |
HLA-A*02:01 MCT2 Neoepitope Tetramer-AMAGSLVFL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| AMAGSLVFL | 4°C | ||||||
|
TS-M241-2 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLA-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLFGDIYLA | 4°C | ||||||
|
TS-M239-2 |
HLA-A*02:01 SPOP Neoepitope Tetramer-FLLDEAIGL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLLDEAIGL | 4°C | ||||||
|
TS-M235-2 |
HLA-A*02:01 Filamin-A Neoepitope Tetramer-HIAKSLFEV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| HIAKSLFEV | 4°C | ||||||
|
TS-M234-2 |
HLA-A*02:01 GAS7 Neoepitope Tetramer-SLADEAEVYL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLADEAEVYL | 4°C | ||||||
|
TS-M228-2 |
HLA-A*02:01 PGML5 Neoepitope Tetramer-AVGSYVYSV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| AVGSYVYSV | 4°C | ||||||
|
TS-M226-2 |
HLA-A*02:01 Astrotactin-1 Neoepitope Tetramer-KLYGLDWAEL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLYGLDWAEL | 4°C | ||||||
|
TS-M221-2 |
HLA-A*02:01 GANAB Neoepitope Tetramer-ALYGFVPVL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALYGFVPVL | 4°C | ||||||
|
TS-M220-2 |
HLA-A*02:01 PRDX5 Neoepitope Tetramer-LLLDDLLVSI-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LLLDDLLVSI | 4°C | ||||||
|
TS-M219-2 |
HLA-A*02:01 SMARCD3 Neoepitope Tetramer-KLFEFLVYGV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLFEFLVYGV | 4°C | ||||||
|
TS-M217-2 |
HLA-A*02:01 ME3 Neoepitope Tetramer-FLDEFMEGV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLDEFMEGV | 4°C | ||||||
|
TS-M213-2 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ACDPHSGHFV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ACDPHSGHFV | 4°C | ||||||
|
TS-M210-2 |
HLA-A*02:01 AHNAK Neoepitope Tetramer-FMPDFDLHL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FMPDFDLHL | 4°C | ||||||
|
TS-M209-2 |
HLA-A*02:01 SRPX Neoepitope Tetramer-TLWCSPIKV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| TLWCSPIKV | 4°C | ||||||
|
TS-M214-1 |
HLA-A*02:01 COL18A1 Neoepitope Tetramer-VLLGVKLFGV-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLLGVKLFGV | 4°C | ||||||
|
TS-M266-2 |
HLA-A*24:02 COASY Neoepitope Tetramer-RFLEYLPLRF-APC
|
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RFLEYLPLRF | 4°C | ||||||
|
TS-M245-2 |
HLA-A*02:01 Sarcospan Neoepitope Tetramer-LMASISSFL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LMASISSFL | 4°C | ||||||
|
TS-M233-2 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-SVLENFTIFL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SVLENFTIFL | 4°C | ||||||
|
TS-M231-2 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| NLNCCSVPV | 4°C | ||||||
|
TS-M229-2 |
HLA-A*02:01 SNX24 Neoepitope Tetramer-KLSHQLVLL-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLSHQLVLL | 4°C | ||||||
|
TS-M225-2 |
HLA-A*02:01 Hsp70 Neoepitope Tetramer-SLFEGIDIYT-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLFEGIDIYT | 4°C | ||||||
|
TS-M222-2 |
HLA-A*02:01 NSDHL Neoepitope Tetramer-ILTGLNYEV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILTGLNYEV | 4°C | ||||||
|
TS-M210-1 |
HLA-A*02:01 AHNAK Neoepitope Tetramer-FMPDFDLHL-PE
|
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FMPDFDLHL | 4°C | ||||||
|
TS-M236-2 |
HLA-A*02:01 PGM5 Neoepitope Tetramer-QQFAVGSYV-APC
|
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| QQFAVGSYV | 4°C | ||||||
|
TS-M265-2 |
HLA-A*24:02 β-catenin Neoepitope Tetramer-SYLDSGIHF-APC
|
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYLDSGIHF | 4°C | ||||||